Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  CellaVision AB (publ)    CEVI   SE0000683484

CELLAVISION AB (PUBL)

(CEVI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Stockholm
11/18/2020 11/19/2020 11/20/2020 11/23/2020 11/24/2020 Date
282(c) 284.6(c) 290(c) 286.6(c) 278.4(c) Last
26 493 39 078 68 410 56 408 56 631 Volume
-0.70% +0.92% +1.90% -1.17% -2.86% Change
More quotes
Financials
Sales 2020 483 M 56,2 M 56,2 M
Net income 2020 90,2 M 10,5 M 10,5 M
Net cash position 2020 64,5 M 7,51 M 7,51 M
P/E ratio 2020 75,8x
Yield 2020 0,53%
Sales 2021 588 M 68,5 M 68,5 M
Net income 2021 130 M 15,1 M 15,1 M
Net cash position 2021 119 M 13,8 M 13,8 M
P/E ratio 2021 52,6x
Yield 2021 0,67%
Capitalization 6 836 M 790 M 795 M
EV / Sales 2020 14,0x
EV / Sales 2021 11,4x
Nbr of Employees -
Free-Float 60,3%
More Financials
Company
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education.... 
More about the company
Notations Surperformance© of CellaVision AB (publ)
Trading Rating : Investor Rating :
More Ratings
All news about CELLAVISION AB (PUBL)
10/23CELLAVISION : Market clearance for CellaVision DC-1 in the US and good profitabi..
AQ
10/14CELLAVISION : The Nomination Committee of CellaVision AB announces that the Chai..
AQ
10/12CELLAVISION PRESENTS THE THIRD QUART : 00 cet
PU
10/12CELLAVISION PRESENTS THE THIRD QUART : 00 cet
AQ
07/16CELLAVISION AB : Good profitability despite negative COVID-19-effect
GL
07/07CellaVision AB presents the second quarter for 2020
GL
06/16CELLAVISION AB : Bulletin from AGM held on June 16, 2020
PU
05/29CELLAVISION AB : Zlatko Rihter leaves his position as CEO at CellaVision AB
GL
05/26CELLAVISION AB : CellaVisions Annual report for 2019 is now available
GL
05/13CELLAVISION AB : Notice of the Annual General Meeting 2020
GL
04/22CELLAVISION AB : Stable start of the year with good growth in APAC
GL
04/15CELLAVISION AB PRESENTS THE FIRST QU : 00 cet
GL
03/26CELLAVISION AB : The Annual General Meeting of CellaVision AB (publ) is postpone..
AQ
03/26CELLAVISION AB : The Annual General Meeting of CellaVision AB (publ) is postpone..
GL
03/20CELLAVISION AB : Notice of 2020 Annual General Meeting of CellaVision (publ)
GL
More news
News in other languages on CELLAVISION AB (PUBL)
09/30AVIS D'ANALYSTES DU JOUR : EasyJet, Givaudan, Lisi, Quadient, Sodexo, Sopra, STM..
2019CELLAVISION AB : Veröffentlichung des Quartalsergebnisses
2019CELLAVISION AB : publication des résultats trimestriels
2019CELLAVISION AB : Veröffentlichung des Jahresergebnisses
2019CELLAVISION AB : publication des résultats annuels
More news
Chart CELLAVISION AB (PUBL)
Duration : Period :
CellaVision AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELLAVISION AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Average target price 325,00 SEK
Last Close Price 286,60 SEK
Spread / Highest target 30,8%
Spread / Average Target 13,4%
Spread / Lowest Target -14,5%
EPS Revisions
Managers
NameTitle
Zlatko Rihter Chief Executive Officer
Sven Gustav Sören Mellstig Chairman
Magnus Blixt Chief Financial Officer
Adam Morell Vice President-Engineering
Anna Yvonne Monica Malm Bernsten Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CELLAVISION AB (PUBL)-12.61%790
SARTORIUS AG98.29%29 084
REVENIO GROUP OYJ56.76%1 289
ALPHATEC HOLDINGS, INC.48.70%827
VAREX IMAGING CORPORATION-45.76%632
OXFORD IMMUNOTEC GLOBAL PLC-17.59%355